Vascular dermatan sulfate regulates the antithrombotic activity of heparin cofactor II
- PMID: 18281504
- PMCID: PMC2288722
- DOI: 10.1182/blood-2007-12-127928
Vascular dermatan sulfate regulates the antithrombotic activity of heparin cofactor II
Abstract
Heparin cofactor II (HCII)-deficient mice form occlusive thrombi more rapidly than do wild-type mice following injury to the carotid arterial endothelium. Dermatan sulfate (DS) and heparan sulfate (HS) increase the rate of inhibition of thrombin by HCII in vitro, but it is unknown whether vascular glycosaminoglycans play a role in the antithrombotic effect of HCII in vivo. In this study, we found that intravenous injection of either wild-type recombinant HCII or a variant with low affinity for HS (K173H) corrected the abnormally short thrombosis time of HCII-deficient mice, while a variant with low affinity for DS (R189H) had no effect. When HCII was incubated with frozen sections of the mouse carotid artery, it bound specifically to DS in the adventitia. HCII was undetectable in the wall of the uninjured carotid artery, but it became concentrated in the adventitia following endothelial injury. These results support the hypothesis that HCII interacts with DS in the vessel wall after disruption of the endothelium and that this interaction regulates thrombus formation in vivo.
Figures







Similar articles
-
Antithrombotic activity of dermatan sulfate in heparin cofactor II-deficient mice.Blood. 2004 Dec 15;104(13):3965-70. doi: 10.1182/blood-2004-02-0598. Epub 2004 Aug 17. Blood. 2004. PMID: 15315969
-
N-Acetylgalactosamine 4,6-O-sulfate residues mediate binding and activation of heparin cofactor II by porcine mucosal dermatan sulfate.Glycobiology. 2006 Aug;16(8):693-701. doi: 10.1093/glycob/cwj117. Epub 2006 Apr 19. Glycobiology. 2006. PMID: 16624894
-
Active site for heparin cofactor II in low molecular mass dermatan sulfate. Contribution to the antithrombotic activity of fractions with high affinity for heparin cofactor II.Thromb Res. 1996 Oct 1;84(1):21-32. doi: 10.1016/0049-3848(96)00158-2. Thromb Res. 1996. PMID: 8885144
-
The interaction of glycosaminoglycans with heparin cofactor II: structure and activity of a high-affinity dermatan sulfate hexasaccharide.Adv Exp Med Biol. 1992;313:167-76. doi: 10.1007/978-1-4899-2444-5_17. Adv Exp Med Biol. 1992. PMID: 1442260 Review.
-
Heparin cofactor II modulates the response to vascular injury.Arterioscler Thromb Vasc Biol. 2007 Mar;27(3):454-60. doi: 10.1161/01.ATV.0000256471.22437.88. Epub 2006 Dec 28. Arterioscler Thromb Vasc Biol. 2007. PMID: 17194895 Review.
Cited by
-
Anticoagulant SERPINs: Endogenous Regulators of Hemostasis and Thrombosis.Front Cardiovasc Med. 2022 May 3;9:878199. doi: 10.3389/fcvm.2022.878199. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 35592395 Free PMC article. Review.
-
Biological functions of iduronic acid in chondroitin/dermatan sulfate.FEBS J. 2013 May;280(10):2431-46. doi: 10.1111/febs.12214. Epub 2013 Mar 28. FEBS J. 2013. PMID: 23441919 Free PMC article. Review.
-
Oral administration of dermatan sulphate reduces venous thrombus formation in vivo: potential use as a formulation for venous thromboembolism.Inflammopharmacology. 2021 Apr;29(2):525-535. doi: 10.1007/s10787-020-00771-x. Epub 2020 Nov 23. Inflammopharmacology. 2021. PMID: 33230702
-
A mouse model of spontaneous preterm birth based on the genetic ablation of biglycan and decorin.Reproduction. 2011 Jul;142(1):183-94. doi: 10.1530/REP-10-0387. Epub 2011 Apr 18. Reproduction. 2011. PMID: 21502335 Free PMC article.
-
The structure of human dermatan sulfate epimerase 1 emphasizes the importance of C5-epimerization of glucuronic acid in higher organisms.Chem Sci. 2020 Dec 8;12(5):1869-1885. doi: 10.1039/d0sc05971d. eCollection 2021 Feb 7. Chem Sci. 2020. PMID: 33815739 Free PMC article.
References
-
- Mann KG. Thrombin formation. Chest. 2003;124:4S–10S. - PubMed
-
- Coughlin SR. Protease-activated receptors in hemostasis, thrombosis and vascular biology. J Thromb Haemost. 2005;3:1800–1814. - PubMed
-
- Bock S. Antithrombin III and heparin cofactor II. In: Colman R, Marder V, Clowes A, George J, Goldhaber S, editors. Hemostasis and Thrombosis: Basic Principles and Clinical Practice. 5th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2006. pp. 235–248.
-
- Tollefsen D, Zhang L. Heparin and vascular proteoglycans. In: Colman R, Marder V, Clowes A, George J, Goldhaber S, editors. Hemostasis and Thrombosis: Basic Principles and Clinical Practice. 5th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2006. pp. 271–283.
-
- Tollefsen DM. Antithrombin deficiency. In: Scriver C, Beaudet A, Sly W, et al., editors. The Metabolic and Molecular Bases of Inherited Disease. 8th ed. New York, NY: McGraw-Hill; 2001. pp. 4455–4471.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases